Spolverato, Gaya
Callegaro, Dario
Gronchi, Alessandro
Article History
First Online: 27 May 2020
Compliance with Ethical Standards
:
: Gaya Spolverato and Dario Callegaro each declare no potential conflict of interest. Alessandro Gronchi, however, has received research funding from PharmaMar, and has received compensation from Novartis, Pfizer, Bayer, Lilly, PharmaMar, SpringWorks Therapeutics, and Nanobiotix for service as a consultant.